Study aims to establish the clinical utility of the EYE-SYNC technology in children and adolescents
Palo Alto, CA — November 19, 2018 — SyncThink, a world leader in neurotechnology with foundational IP in eye tracking analytics announces today that Children’s National Medical Center in D.C., ranked among the top five children’s hospitals in the nation and the premier provider of pediatric care in the D.C. region, will launch a new study in the examination of ocular motor deficits in children and adolescents with concussion. The year-long investigation will focus on collecting normative performance data and evidence for reliability and validation of the EYE-SYNC technology for patients aged six to sixteen.
Study aims to establish the clinical utility of the EYE-SYNC technology in children and adolescents
Palo Alto, CA — November 19, 2018 — SyncThink, a world leader in neurotechnology with foundational IP in eye tracking analytics announces today that Children’s National Medical Center in D.C., ranked among the top five children’s hospitals in the nation and the premier provider of pediatric care in the D.C. region, will launch a new study in the examination of ocular motor deficits in children and adolescents with concussion. The year-long investigation will focus on collecting normative performance data and evidence for reliability and validation of the EYE-SYNC technology for patients aged six to sixteen.
Leading the study are physicians and researchers Gerard Gioia and Christopher Vaughan, the Director and Assistant Director of the Children’s National Safe Concussion Outcome Recovery and Education (SCORE) program.
“The SCORE program at Children’s National was established in 2003 with the mission of promoting developmentally appropriate assessment and treatment for children with concussion,” Dr. Vaughan said. “Measuring eye tracking in youth with the EYE-SYNC product may improve our multimodal and developmentally sensitive assessment process.”
“As one of the funders of this initiative, we strongly believe in the positive impact of leading-edge innovation and technology on the healthcare of children,” said Raul Fernandez, Founder of The Fernandez Foundation.
A great need exists in the pediatric population for early detection and appropriate, early intervention of concussion, in order to promote full recovery without the risk of complications. The SCORE team will utilize the EYE-SYNC technology in part to better understand and recognize ocular motor issues seen commonly after injury.
“By identifying ocular motor specific problems after concussion, we can move toward providing early targeted treatment interventions for these kids with ocular motor and vestibular problems after injury,” Dr. Vaughan stated.
Children’s National joins a large network of SyncThink platform users across the research, clinical, military, and sport landscapes. The technology is already in use in over 30 care settings across North America including Stanford Children’s Health, Massachusetts General Hospital, and Walter Reed Army Institute of Research. In addition, the Pac-12 conference, University of Texas, University of Georgia, Golden State Warriors, and Atlanta Hawks have also acquired the technology to improve monitoring and care of athletes through the SyncThink brain health analytics platform.
“This is a tremendous opportunity to collaborate with a premier medical center and their esteemed faculty in Dr. Gioia and Dr. Vaughan, to help establish the EYE-SYNC technology as a reliable assessment tool for the care of children and teens,” SyncThink CEO, Laura Yecies said.
Children’s National is one of the most prestigious and trusted pediatric programs in the country and is recognized nationally on a regular basis for excellence in areas of patient care, research, innovation, and technology.
About SyncThink
SyncThink is on a mission to provide objective measurements for brain health and empower people to maximize their health and performance. SyncThink develops revolutionary eye-tracking technology and analytics, in a VR environment, that assist medical professionals in assessing brain health, monitoring recovery, and optimizing performance. With more than 30 published peer-reviewed papers and 12 granted patents, the SyncThink platform uses a series of 60-second assessments to objectively measure eye movements to identify impairments and offers multiple modalities to train dynamic vision. FDA-cleared for detecting eye-tracking impairment and used by leading medical centers such as Stanford and Massachusetts General, the U.S. military, and more than 20 top universities, SyncThink is transforming assessment, recovery, and performance for life and sport. www.syncthink.com
